GerardBungee的个人主页 - 老虎社区

GerardBungee

GerardBungee

暂无个人介绍

IP属地：未知

40关注

1粉丝

1主题

0勋章

2021-12-18

Wow

Wall Street ends down after mostly negative week

2021-12-18

Wow

Why Pfizer and Johnson & Johnson Fell on Friday

2021-11-09

$Palantir Technologies Inc.(PLTR)$to the moon?

2021-12-23

Wow

Canopy Growth Stock Is Downgraded Again, This Time on ‘Execution Challenges’

2021-10-25

$Riot Blockchain, Inc.(RIOT)$long term potential?

2021-12-23

Ttm

Netflix Stock: Why It Might Outperform Rivals in 2022

2021-11-07

Wow

@Yonny:Rivian is a better buy than Lucid, IMO

2021-11-05

$UiPath(PATH)$great potential !

2021-11-01

$Paysafe Ltd(PSFE)$yay or nay?

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3577068348393147,"uuid":"3577068348393147","gmtCreate":1613979471223,"gmtModify":1624002657399,"name":"GerardBungee","pinyin":"gerardbungee","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/ed18bbfb3b78ae0c31b89056409c9938","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":40,"tweetSize":10,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.18%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.12","exceedPercentage":"93.24%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.08","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":691707989,"gmtCreate":1640237633301,"gmtModify":1640237633362,"author":{"id":"3577068348393147","authorId":"3577068348393147","name":"GerardBungee","avatar":"https://static.tigerbbs.com/ed18bbfb3b78ae0c31b89056409c9938","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691707989","repostId":"1103220602","repostType":4,"repost":{"id":"1103220602","pubTimestamp":1640237254,"share":"https://www.laohu8.com/m/news/1103220602?lang=&edition=full","pubTime":"2021-12-23 13:27","market":"us","language":"en","title":"Canopy Growth Stock Is Downgraded Again, This Time on ‘Execution Challenges’","url":"https://stock-news.laohu8.com/highlight/detail?id=1103220602","media":"Barrons","summary":"Canopy Growth was downgraded at BofA Securities with the analysts noting “execution challenges and a","content":"<p>Canopy Growth&nbsp;was downgraded at BofA Securities with the analysts noting “execution challenges and a tough Canadian&nbsp;operating environment.”</p>\n<p>Analyst Lisa Lewandowski wrote in a note Wednesday that she sees “long-term potential for the legal cannabis industry driven by U.S. federal legalization and changing attitudes toward cannabis consumption,” but was downgrading the stock of Canopy Growth (ticker: CGC) to Underperform from Neutral.</p>\n<p>U.S.-listed shares of the Canadian cannabis company fell 3% to $9.37. The stock has declined 62% in 2021.</p>\n<p>Lewandowski said Canopy Growth’s relationship with&nbsp;Constellation Brands&nbsp;(STZ) was a plus, but the company “has shown&nbsp;mixed progress on key performance metrics, is&nbsp;confronted&nbsp;with&nbsp;a rapidly&nbsp;evolving&nbsp;Canadian market with new entrants taking&nbsp;market&nbsp;share&nbsp;and changing consumer tastes,&nbsp;lackluster industry growth&nbsp;even with&nbsp;new stores&nbsp;opening and&nbsp;limited visibility for&nbsp;profitability.”</p>\n<p>Constellation Brands owns a 36% stake in Canopy Growth, according to FactSet.</p>\n<p>Recent management changes at the company and the planned sale of C3, a German pharmaceutical company, were efforts at Canopy Growth that “will take time to show results,” the analyst said.</p>\n<p>BofA reduced its price target on U.S. shares to $7.94&nbsp;from&nbsp;$15.15.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canopy Growth Stock Is Downgraded Again, This Time on ‘Execution Challenges’</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanopy Growth Stock Is Downgraded Again, This Time on ‘Execution Challenges’\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 13:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/canopy-growth-cgc-stock-downgrade-cannabis-51640192812?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth was downgraded at BofA Securities with the analysts noting “execution challenges and a tough Canadian operating environment.”\nAnalyst Lisa Lewandowski wrote in a note Wednesday that she ...</p>\n\n<a href=\"https://www.barrons.com/articles/canopy-growth-cgc-stock-downgrade-cannabis-51640192812?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CGC":"Canopy Growth Corporation"},"source_url":"https://www.barrons.com/articles/canopy-growth-cgc-stock-downgrade-cannabis-51640192812?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1103220602","content_text":"Canopy Growth was downgraded at BofA Securities with the analysts noting “execution challenges and a tough Canadian operating environment.”\nAnalyst Lisa Lewandowski wrote in a note Wednesday that she sees “long-term potential for the legal cannabis industry driven by U.S. federal legalization and changing attitudes toward cannabis consumption,” but was downgrading the stock of Canopy Growth (ticker: CGC) to Underperform from Neutral.\nU.S.-listed shares of the Canadian cannabis company fell 3% to $9.37. The stock has declined 62% in 2021.\nLewandowski said Canopy Growth’s relationship with Constellation Brands (STZ) was a plus, but the company “has shown mixed progress on key performance metrics, is confronted with a rapidly evolving Canadian market with new entrants taking market share and changing consumer tastes, lackluster industry growth even with new stores opening and limited visibility for profitability.”\nConstellation Brands owns a 36% stake in Canopy Growth, according to FactSet.\nRecent management changes at the company and the planned sale of C3, a German pharmaceutical company, were efforts at Canopy Growth that “will take time to show results,” the analyst said.\nBofA reduced its price target on U.S. shares to $7.94 from $15.15.","news_type":1},"isVote":1,"tweetType":1,"viewCount":342,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691707041,"gmtCreate":1640237607418,"gmtModify":1640237607478,"author":{"id":"3577068348393147","authorId":"3577068348393147","name":"GerardBungee","avatar":"https://static.tigerbbs.com/ed18bbfb3b78ae0c31b89056409c9938","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Ttm","listText":"Ttm","text":"Ttm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691707041","repostId":"1132132037","repostType":4,"repost":{"id":"1132132037","pubTimestamp":1640236963,"share":"https://www.laohu8.com/m/news/1132132037?lang=&edition=full","pubTime":"2021-12-23 13:22","market":"us","language":"en","title":"Netflix Stock: Why It Might Outperform Rivals in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1132132037","media":"TheStreet","summary":"Could 2022 be a great year for Netflix stock? Here's why shares of the streaming platform may outper","content":"<p>Could 2022 be a great year for Netflix stock? Here's why shares of the streaming platform may outperform its competitors again next year.</p>\n<p>After Netflix's&nbsp;great stock performance in 2021, fans of the streaming service are wondering what's in store for the company and its shares in 2022.</p>\n<p>Let's sum up what happened to NFLX shares this year and whether they still present a good opportunity for investors.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a2b3cf4fdc5d06fd34521575cb3c69b3\" tg-width=\"1240\" tg-height=\"812\" width=\"100%\" height=\"auto\"><span>Figure 1: Netflix's office.</span></p>\n<p><b>Netflix's 2021 Revenue Results</b></p>\n<p>Looking at company revenue, Netflix continued to grow during 2021 but experienced a slowdown compared to 2020. This was likely due to the subscription boom the company experienced during 2020 thanks to COVID lockdowns.</p>\n<p>Even so, during the last three quarters, Netflix's revenue showed year-over-year average revenue growth of 20%. In addition, its operating margins rose from 20.4% in the third quarter of 2020 to 23.5% in the third quarter of 2021.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2f704b36024b940ec42ace68116770a9\" tg-width=\"949\" tg-height=\"438\" width=\"100%\" height=\"auto\"><span>Figure 2: Netflix's financial statements.</span></p>\n<p>Subscriber growth is another key metric for investors. Unfortunately, results here were disappointing in 2021.</p>\n<p>In 2020, Netflix's subscriber growth was more than 20% per quarter. This dropped to 10% in 2021.</p>\n<p>However, investors should take it into account that, during the early months of the pandemic, the company experienced record-breaking growth. The decrease we've seen this year may just be the result of subscriber growth returning to normal levels.</p>\n<p><b>How Did NFLX Perform Against Other Streaming Services?</b></p>\n<p>Compared to its competitors, NFLX did very well in 2021 with cumulative growth of 16%. Other stocks that compete in the video streaming segment saw worse returns. For example, Amazon&nbsp;shares appreciated only 5%, while Disney&nbsp;suffered a drop of nearly 20%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bd970e1a30a0271380825554f364907d\" tg-width=\"811\" tg-height=\"428\" width=\"100%\" height=\"auto\"><span>Figure 3: AMZN, DIS, NFLX and SPY performance in 2021.</span></p>\n<p>However, NFLX's performance looks less stellar when compared to companies outside the streaming segment. In fact, the stock underperformed the S&amp;P 500 in 2021.</p>\n<p>As Netflix stock moves away from its peak in November, there may still be room for the company to grow.</p>\n<p><b>What's Next?: Our Take on NFLX for 2022</b></p>\n<p>Netflix was a pioneer in the video streaming segment. And despite fierce competition from giants like Disney and Amazon, it still has the largest market share in the industry.</p>\n<p>In addition, Netflix is constantly betting on new segments for revenue growth. For example, it recently pushed beyond films by launching an interactive games division. Moves like this expose Netflix to new subscribers and boost its bottom line.</p>\n<p>We believe that the recent fall in NFLX’s stock price translates to a buying opportunity for long-term investors who agree there’s still plenty of growth to come.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Netflix Stock: Why It Might Outperform Rivals in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNetflix Stock: Why It Might Outperform Rivals in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 13:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/streaming/nflx/netflix-stock-should-you-buy-nflx-shares-in-2022><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Could 2022 be a great year for Netflix stock? Here's why shares of the streaming platform may outperform its competitors again next year.\nAfter Netflix's great stock performance in 2021, fans of the ...</p>\n\n<a href=\"https://www.thestreet.com/streaming/nflx/netflix-stock-should-you-buy-nflx-shares-in-2022\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NFLX":"奈飞"},"source_url":"https://www.thestreet.com/streaming/nflx/netflix-stock-should-you-buy-nflx-shares-in-2022","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1132132037","content_text":"Could 2022 be a great year for Netflix stock? Here's why shares of the streaming platform may outperform its competitors again next year.\nAfter Netflix's great stock performance in 2021, fans of the streaming service are wondering what's in store for the company and its shares in 2022.\nLet's sum up what happened to NFLX shares this year and whether they still present a good opportunity for investors.\nFigure 1: Netflix's office.\nNetflix's 2021 Revenue Results\nLooking at company revenue, Netflix continued to grow during 2021 but experienced a slowdown compared to 2020. This was likely due to the subscription boom the company experienced during 2020 thanks to COVID lockdowns.\nEven so, during the last three quarters, Netflix's revenue showed year-over-year average revenue growth of 20%. In addition, its operating margins rose from 20.4% in the third quarter of 2020 to 23.5% in the third quarter of 2021.\nFigure 2: Netflix's financial statements.\nSubscriber growth is another key metric for investors. Unfortunately, results here were disappointing in 2021.\nIn 2020, Netflix's subscriber growth was more than 20% per quarter. This dropped to 10% in 2021.\nHowever, investors should take it into account that, during the early months of the pandemic, the company experienced record-breaking growth. The decrease we've seen this year may just be the result of subscriber growth returning to normal levels.\nHow Did NFLX Perform Against Other Streaming Services?\nCompared to its competitors, NFLX did very well in 2021 with cumulative growth of 16%. Other stocks that compete in the video streaming segment saw worse returns. For example, Amazon shares appreciated only 5%, while Disney suffered a drop of nearly 20%.\nFigure 3: AMZN, DIS, NFLX and SPY performance in 2021.\nHowever, NFLX's performance looks less stellar when compared to companies outside the streaming segment. In fact, the stock underperformed the S&P 500 in 2021.\nAs Netflix stock moves away from its peak in November, there may still be room for the company to grow.\nWhat's Next?: Our Take on NFLX for 2022\nNetflix was a pioneer in the video streaming segment. And despite fierce competition from giants like Disney and Amazon, it still has the largest market share in the industry.\nIn addition, Netflix is constantly betting on new segments for revenue growth. For example, it recently pushed beyond films by launching an interactive games division. Moves like this expose Netflix to new subscribers and boost its bottom line.\nWe believe that the recent fall in NFLX’s stock price translates to a buying opportunity for long-term investors who agree there’s still plenty of growth to come.","news_type":1},"isVote":1,"tweetType":1,"viewCount":678,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699210643,"gmtCreate":1639806751781,"gmtModify":1639806751781,"author":{"id":"3577068348393147","authorId":"3577068348393147","name":"GerardBungee","avatar":"https://static.tigerbbs.com/ed18bbfb3b78ae0c31b89056409c9938","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699210643","repostId":"1109831591","repostType":4,"repost":{"id":"1109831591","pubTimestamp":1639804463,"share":"https://www.laohu8.com/m/news/1109831591?lang=&edition=full","pubTime":"2021-12-18 13:14","market":"us","language":"en","title":"Why Pfizer and Johnson & Johnson Fell on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1109831591","media":"Motley Fool","summary":"What happened\nTwo prominent U.S. coronavirus stocks ended the week on a down note. Pfizer and Johnso","content":"<p>What happened</p>\n<p>Two prominent U.S. coronavirus stocks ended the week on a down note.&nbsp;<a href=\"https://laohu8.com/S/PFE\"><b>Pfizer</b></a>&nbsp;and&nbsp;<a href=\"https://laohu8.com/S/JNJ\"><b>Johnson &amp; Johnson</b></a>&nbsp;both fell on the day by nearly 3%. This followed a prominent investment bank's rather lukewarm take on their current prospects.</p>\n<p><img src=\"https://static.tigerbbs.com/c6a2f152eebbe10f5ab65a99815f461c\" tg-width=\"975\" tg-height=\"637\" width=\"100%\" height=\"auto\"></p>\n<p>So what</p>\n<p><b>Goldman Sachs</b>&nbsp;analyst Chris Shibutani initiated coverage on Pfizer and Johnson &amp; Johnson on Friday, tagging both high-profile healthcare industry stocks with neutral recommendations.</p>\n<p>Shibutani is concerned with what he considers to be Pfizer's somewhat cloudy future, despite the great success of the Comirnaty coronavirus vaccine it developed with Germanbiotech&nbsp;<b>BioNTech</b>.</p>\n<p>\"Our views on [Pfizer] come down to that we estimate around one-third of its current valuation is attributed to the COVID-19 vaccine and therapeutic [products], and we feel the trajectory for both remains highly uncertain,\" he wrote.</p>\n<p>As for Johnson &amp; Johnson, the prognosticator feels the stock is also fairly valued. However, he sounded a more optimistic note about the company's potential.</p>\n<p>\"With [Johnson &amp; Johnson] in the midst of transitions across several domains for the organization ... we see possibilities -- even within an organization of [Johnson &amp; Johnson]'s scale and scope -- for additional potentially disruptive opportunities to develop that could reshape the investment thesis, in our view,\" he wrote.</p>\n<p>Last month, Johnson &amp; Johnson announced plans to spin off its sprawlingconsumer healthcare division.</p>\n<p>Shibutani's price target on Pfizer stock is $51 per share, and that for Johnson &amp; Johnson is $161.</p>\n<p>Now what</p>\n<p>Pfizer and Johnson &amp; Johnson are certainly heading into some uncertain waters -- both with the coronavirus and, in the latter company's case, the apparently looming spinoff. To my mind, though, the two companies have plenty of strength in numerous product areas outside of their respective vaccines, so investors shouldn't be too discouraged by Goldman Sachs' latest evaluations.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer and Johnson & Johnson Fell on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer and Johnson & Johnson Fell on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 13:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/17/why-pfizer-and-johnson-johnson-fell-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\nTwo prominent U.S. coronavirus stocks ended the week on a down note. Pfizer and Johnson & Johnson both fell on the day by nearly 3%. This followed a prominent investment bank's rather ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/17/why-pfizer-and-johnson-johnson-fell-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2021/12/17/why-pfizer-and-johnson-johnson-fell-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1109831591","content_text":"What happened\nTwo prominent U.S. coronavirus stocks ended the week on a down note. Pfizer and Johnson & Johnson both fell on the day by nearly 3%. This followed a prominent investment bank's rather lukewarm take on their current prospects.\n\nSo what\nGoldman Sachs analyst Chris Shibutani initiated coverage on Pfizer and Johnson & Johnson on Friday, tagging both high-profile healthcare industry stocks with neutral recommendations.\nShibutani is concerned with what he considers to be Pfizer's somewhat cloudy future, despite the great success of the Comirnaty coronavirus vaccine it developed with Germanbiotech BioNTech.\n\"Our views on [Pfizer] come down to that we estimate around one-third of its current valuation is attributed to the COVID-19 vaccine and therapeutic [products], and we feel the trajectory for both remains highly uncertain,\" he wrote.\nAs for Johnson & Johnson, the prognosticator feels the stock is also fairly valued. However, he sounded a more optimistic note about the company's potential.\n\"With [Johnson & Johnson] in the midst of transitions across several domains for the organization ... we see possibilities -- even within an organization of [Johnson & Johnson]'s scale and scope -- for additional potentially disruptive opportunities to develop that could reshape the investment thesis, in our view,\" he wrote.\nLast month, Johnson & Johnson announced plans to spin off its sprawlingconsumer healthcare division.\nShibutani's price target on Pfizer stock is $51 per share, and that for Johnson & Johnson is $161.\nNow what\nPfizer and Johnson & Johnson are certainly heading into some uncertain waters -- both with the coronavirus and, in the latter company's case, the apparently looming spinoff. To my mind, though, the two companies have plenty of strength in numerous product areas outside of their respective vaccines, so investors shouldn't be too discouraged by Goldman Sachs' latest evaluations.","news_type":1},"isVote":1,"tweetType":1,"viewCount":568,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699210377,"gmtCreate":1639806704296,"gmtModify":1639806704394,"author":{"id":"3577068348393147","authorId":"3577068348393147","name":"GerardBungee","avatar":"https://static.tigerbbs.com/ed18bbfb3b78ae0c31b89056409c9938","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699210377","repostId":"1116106959","repostType":4,"repost":{"id":"1116106959","pubTimestamp":1639785552,"share":"https://www.laohu8.com/m/news/1116106959?lang=&edition=full","pubTime":"2021-12-18 07:59","market":"us","language":"en","title":"Wall Street ends down after mostly negative week","url":"https://stock-news.laohu8.com/highlight/detail?id=1116106959","media":"Reuters","summary":" - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.The S","content":"<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.</p>\n<p>All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.</p>\n<p>Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&amp;P 500 and Nasdaq.</p>\n<p>The S&amp;P 500 growth index lost 0.7% and the value index declined 1.4%.</p>\n<p>All of the 11 major S&amp;P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.</p>\n<p>Adding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.</p>\n<p>Traders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.</p>\n<p>\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"</p>\n<p>Heavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&amp;P 500 index gained around 23% in the same period.</p>\n<p>In Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&amp;P 500 lost 1.03% to 4,620.64.</p>\n<p>The Nasdaq Composite dropped 0.07% to 15,169.68.</p>\n<p>On a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.</p>\n<p>With options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.</p>\n<p>For the week, the S&amp;P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.</p>\n<p>In Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.</p>\n<p>FedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down after mostly negative week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down after mostly negative week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 07:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116106959","content_text":"(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.\nAll three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.\nNvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.\nThe S&P 500 growth index lost 0.7% and the value index declined 1.4%.\nAll of the 11 major S&P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.\nAdding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.\nTraders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.\n\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"\nHeavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&P 500 index gained around 23% in the same period.\nIn Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&P 500 lost 1.03% to 4,620.64.\nThe Nasdaq Composite dropped 0.07% to 15,169.68.\nOn a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.\nWith options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.\nFor the week, the S&P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.\nIn Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.\nFedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.\nThe S&P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":372,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844780425,"gmtCreate":1636460263437,"gmtModify":1636460263437,"author":{"id":"3577068348393147","authorId":"3577068348393147","name":"GerardBungee","avatar":"https://static.tigerbbs.com/ed18bbfb3b78ae0c31b89056409c9938","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>to the moon?","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>to the moon?","text":"$Palantir Technologies Inc.(PLTR)$to the moon?","images":[{"img":"https://static.tigerbbs.com/9a61a585080c9a0507d3aad366400415","width":"1080","height":"2528"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844780425","isVote":1,"tweetType":1,"viewCount":515,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":845132423,"gmtCreate":1636299004466,"gmtModify":1636299004587,"author":{"id":"3577068348393147","authorId":"3577068348393147","name":"GerardBungee","avatar":"https://static.tigerbbs.com/ed18bbfb3b78ae0c31b89056409c9938","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/845132423","repostId":"843244545","repostType":1,"repost":{"id":843244545,"gmtCreate":1635836949483,"gmtModify":1636092763588,"author":{"id":"3579612413176972","authorId":"3579612413176972","name":"Yonny","avatar":"https://static.tigerbbs.com/231a2860cddd1bf2ffc3c16938f4673d","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"title":"Rivian is a better buy than Lucid, IMO","htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/RIVN\">$Rivian Automotive, Inc.(RIVN)$</a>,the&nbsp;EV&nbsp;automaker and automotive technology company&nbsp;is&nbsp;going&nbsp;to go public as soon as next week,&nbsp;and&nbsp;retail traders can&nbsp;get into&nbsp;the IPO&nbsp;on&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>.&nbsp; Rivian&nbsp;said&nbsp;it is offering 135 million shares priced between $57 and $62,&nbsp;putting valuation up&nbsp;to&nbsp;near $55 billion.&nbsp;And&nbsp;the&nbsp;company&nbsp;is&nbsp;backed by&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/AMZN\">$Amazon.com(AMZN)$</a> and&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/F\">$Ford(F)$</a> So&nbsp;compared&nbsp;to&nbsp;","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/RIVN\">$Rivian Automotive, Inc.(RIVN)$</a>,the&nbsp;EV&nbsp;automaker and automotive technology company&nbsp;is&nbsp;going&nbsp;to go public as soon as next week,&nbsp;and&nbsp;retail traders can&nbsp;get into&nbsp;the IPO&nbsp;on&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>.&nbsp; Rivian&nbsp;said&nbsp;it is offering 135 million shares priced between $57 and $62,&nbsp;putting valuation up&nbsp;to&nbsp;near $55 billion.&nbsp;And&nbsp;the&nbsp;company&nbsp;is&nbsp;backed by&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/AMZN\">$Amazon.com(AMZN)$</a> and&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/F\">$Ford(F)$</a> So&nbsp;compared&nbsp;to&nbsp;","text":"$Rivian Automotive, Inc.(RIVN)$,the EV automaker and automotive technology company is going to go public as soon as next week, and retail traders can get into the IPO on $SoFi Technologies Inc.(SOFI)$. Rivian said it is offering 135 million shares priced between $57 and $62, putting valuation up to near $55 billion. And the company is backed by $Amazon.com(AMZN)$ and $Ford(F)$ So compared to","images":[{"img":"https://static.tigerbbs.com/2547c8ce512a5377c138129416f63e64","width":"1780","height":"680"}],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843244545","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":519,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846880415,"gmtCreate":1636072707706,"gmtModify":1636072707778,"author":{"id":"3577068348393147","authorId":"3577068348393147","name":"GerardBungee","avatar":"https://static.tigerbbs.com/ed18bbfb3b78ae0c31b89056409c9938","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PATH\">$UiPath(PATH)$</a>great potential !","listText":"<a href=\"https://laohu8.com/S/PATH\">$UiPath(PATH)$</a>great potential !","text":"$UiPath(PATH)$great potential !","images":[{"img":"https://static.tigerbbs.com/6b2be22fd819b32b2426fddd05133612","width":"1080","height":"2528"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846880415","isVote":1,"tweetType":1,"viewCount":622,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":849477604,"gmtCreate":1635775742226,"gmtModify":1635775742291,"author":{"id":"3577068348393147","authorId":"3577068348393147","name":"GerardBungee","avatar":"https://static.tigerbbs.com/ed18bbfb3b78ae0c31b89056409c9938","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PSFE\">$Paysafe Ltd(PSFE)$</a>yay or nay?","listText":"<a href=\"https://laohu8.com/S/PSFE\">$Paysafe Ltd(PSFE)$</a>yay or nay?","text":"$Paysafe Ltd(PSFE)$yay or nay?","images":[{"img":"https://static.tigerbbs.com/8a848c0d4f7c259222fcb06e09bed5dc","width":"1080","height":"2429"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849477604","isVote":1,"tweetType":1,"viewCount":460,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":856605792,"gmtCreate":1635171634857,"gmtModify":1635171635042,"author":{"id":"3577068348393147","authorId":"3577068348393147","name":"GerardBungee","avatar":"https://static.tigerbbs.com/ed18bbfb3b78ae0c31b89056409c9938","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RIOT\">$Riot Blockchain, Inc.(RIOT)$</a>long term potential?","listText":"<a href=\"https://laohu8.com/S/RIOT\">$Riot Blockchain, Inc.(RIOT)$</a>long term potential?","text":"$Riot Blockchain, Inc.(RIOT)$long term potential?","images":[{"img":"https://static.tigerbbs.com/0df16469a1cce9c32ef8adb73777328b","width":"1080","height":"2429"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/856605792","isVote":1,"tweetType":1,"viewCount":349,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"hots":[{"id":699210377,"gmtCreate":1639806704296,"gmtModify":1639806704394,"author":{"id":"3577068348393147","authorId":"3577068348393147","name":"GerardBungee","avatar":"https://static.tigerbbs.com/ed18bbfb3b78ae0c31b89056409c9938","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699210377","repostId":"1116106959","repostType":4,"repost":{"id":"1116106959","pubTimestamp":1639785552,"share":"https://www.laohu8.com/m/news/1116106959?lang=&edition=full","pubTime":"2021-12-18 07:59","market":"us","language":"en","title":"Wall Street ends down after mostly negative week","url":"https://stock-news.laohu8.com/highlight/detail?id=1116106959","media":"Reuters","summary":" - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.The S","content":"<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.</p>\n<p>All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.</p>\n<p>Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&amp;P 500 and Nasdaq.</p>\n<p>The S&amp;P 500 growth index lost 0.7% and the value index declined 1.4%.</p>\n<p>All of the 11 major S&amp;P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.</p>\n<p>Adding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.</p>\n<p>Traders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.</p>\n<p>\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"</p>\n<p>Heavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&amp;P 500 index gained around 23% in the same period.</p>\n<p>In Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&amp;P 500 lost 1.03% to 4,620.64.</p>\n<p>The Nasdaq Composite dropped 0.07% to 15,169.68.</p>\n<p>On a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.</p>\n<p>With options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.</p>\n<p>For the week, the S&amp;P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.</p>\n<p>In Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.</p>\n<p>FedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down after mostly negative week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down after mostly negative week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 07:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116106959","content_text":"(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.\nAll three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.\nNvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.\nThe S&P 500 growth index lost 0.7% and the value index declined 1.4%.\nAll of the 11 major S&P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.\nAdding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.\nTraders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.\n\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"\nHeavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&P 500 index gained around 23% in the same period.\nIn Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&P 500 lost 1.03% to 4,620.64.\nThe Nasdaq Composite dropped 0.07% to 15,169.68.\nOn a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.\nWith options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.\nFor the week, the S&P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.\nIn Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.\nFedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.\nThe S&P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":372,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699210643,"gmtCreate":1639806751781,"gmtModify":1639806751781,"author":{"id":"3577068348393147","authorId":"3577068348393147","name":"GerardBungee","avatar":"https://static.tigerbbs.com/ed18bbfb3b78ae0c31b89056409c9938","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699210643","repostId":"1109831591","repostType":4,"repost":{"id":"1109831591","pubTimestamp":1639804463,"share":"https://www.laohu8.com/m/news/1109831591?lang=&edition=full","pubTime":"2021-12-18 13:14","market":"us","language":"en","title":"Why Pfizer and Johnson & Johnson Fell on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1109831591","media":"Motley Fool","summary":"What happened\nTwo prominent U.S. coronavirus stocks ended the week on a down note. Pfizer and Johnso","content":"<p>What happened</p>\n<p>Two prominent U.S. coronavirus stocks ended the week on a down note.&nbsp;<a href=\"https://laohu8.com/S/PFE\"><b>Pfizer</b></a>&nbsp;and&nbsp;<a href=\"https://laohu8.com/S/JNJ\"><b>Johnson &amp; Johnson</b></a>&nbsp;both fell on the day by nearly 3%. This followed a prominent investment bank's rather lukewarm take on their current prospects.</p>\n<p><img src=\"https://static.tigerbbs.com/c6a2f152eebbe10f5ab65a99815f461c\" tg-width=\"975\" tg-height=\"637\" width=\"100%\" height=\"auto\"></p>\n<p>So what</p>\n<p><b>Goldman Sachs</b>&nbsp;analyst Chris Shibutani initiated coverage on Pfizer and Johnson &amp; Johnson on Friday, tagging both high-profile healthcare industry stocks with neutral recommendations.</p>\n<p>Shibutani is concerned with what he considers to be Pfizer's somewhat cloudy future, despite the great success of the Comirnaty coronavirus vaccine it developed with Germanbiotech&nbsp;<b>BioNTech</b>.</p>\n<p>\"Our views on [Pfizer] come down to that we estimate around one-third of its current valuation is attributed to the COVID-19 vaccine and therapeutic [products], and we feel the trajectory for both remains highly uncertain,\" he wrote.</p>\n<p>As for Johnson &amp; Johnson, the prognosticator feels the stock is also fairly valued. However, he sounded a more optimistic note about the company's potential.</p>\n<p>\"With [Johnson &amp; Johnson] in the midst of transitions across several domains for the organization ... we see possibilities -- even within an organization of [Johnson &amp; Johnson]'s scale and scope -- for additional potentially disruptive opportunities to develop that could reshape the investment thesis, in our view,\" he wrote.</p>\n<p>Last month, Johnson &amp; Johnson announced plans to spin off its sprawlingconsumer healthcare division.</p>\n<p>Shibutani's price target on Pfizer stock is $51 per share, and that for Johnson &amp; Johnson is $161.</p>\n<p>Now what</p>\n<p>Pfizer and Johnson &amp; Johnson are certainly heading into some uncertain waters -- both with the coronavirus and, in the latter company's case, the apparently looming spinoff. To my mind, though, the two companies have plenty of strength in numerous product areas outside of their respective vaccines, so investors shouldn't be too discouraged by Goldman Sachs' latest evaluations.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer and Johnson & Johnson Fell on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer and Johnson & Johnson Fell on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 13:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/17/why-pfizer-and-johnson-johnson-fell-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\nTwo prominent U.S. coronavirus stocks ended the week on a down note. Pfizer and Johnson & Johnson both fell on the day by nearly 3%. This followed a prominent investment bank's rather ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/17/why-pfizer-and-johnson-johnson-fell-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2021/12/17/why-pfizer-and-johnson-johnson-fell-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1109831591","content_text":"What happened\nTwo prominent U.S. coronavirus stocks ended the week on a down note. Pfizer and Johnson & Johnson both fell on the day by nearly 3%. This followed a prominent investment bank's rather lukewarm take on their current prospects.\n\nSo what\nGoldman Sachs analyst Chris Shibutani initiated coverage on Pfizer and Johnson & Johnson on Friday, tagging both high-profile healthcare industry stocks with neutral recommendations.\nShibutani is concerned with what he considers to be Pfizer's somewhat cloudy future, despite the great success of the Comirnaty coronavirus vaccine it developed with Germanbiotech BioNTech.\n\"Our views on [Pfizer] come down to that we estimate around one-third of its current valuation is attributed to the COVID-19 vaccine and therapeutic [products], and we feel the trajectory for both remains highly uncertain,\" he wrote.\nAs for Johnson & Johnson, the prognosticator feels the stock is also fairly valued. However, he sounded a more optimistic note about the company's potential.\n\"With [Johnson & Johnson] in the midst of transitions across several domains for the organization ... we see possibilities -- even within an organization of [Johnson & Johnson]'s scale and scope -- for additional potentially disruptive opportunities to develop that could reshape the investment thesis, in our view,\" he wrote.\nLast month, Johnson & Johnson announced plans to spin off its sprawlingconsumer healthcare division.\nShibutani's price target on Pfizer stock is $51 per share, and that for Johnson & Johnson is $161.\nNow what\nPfizer and Johnson & Johnson are certainly heading into some uncertain waters -- both with the coronavirus and, in the latter company's case, the apparently looming spinoff. To my mind, though, the two companies have plenty of strength in numerous product areas outside of their respective vaccines, so investors shouldn't be too discouraged by Goldman Sachs' latest evaluations.","news_type":1},"isVote":1,"tweetType":1,"viewCount":568,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844780425,"gmtCreate":1636460263437,"gmtModify":1636460263437,"author":{"id":"3577068348393147","authorId":"3577068348393147","name":"GerardBungee","avatar":"https://static.tigerbbs.com/ed18bbfb3b78ae0c31b89056409c9938","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>to the moon?","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>to the moon?","text":"$Palantir Technologies Inc.(PLTR)$to the moon?","images":[{"img":"https://static.tigerbbs.com/9a61a585080c9a0507d3aad366400415","width":"1080","height":"2528"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844780425","isVote":1,"tweetType":1,"viewCount":515,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":691707989,"gmtCreate":1640237633301,"gmtModify":1640237633362,"author":{"id":"3577068348393147","authorId":"3577068348393147","name":"GerardBungee","avatar":"https://static.tigerbbs.com/ed18bbfb3b78ae0c31b89056409c9938","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691707989","repostId":"1103220602","repostType":4,"repost":{"id":"1103220602","pubTimestamp":1640237254,"share":"https://www.laohu8.com/m/news/1103220602?lang=&edition=full","pubTime":"2021-12-23 13:27","market":"us","language":"en","title":"Canopy Growth Stock Is Downgraded Again, This Time on ‘Execution Challenges’","url":"https://stock-news.laohu8.com/highlight/detail?id=1103220602","media":"Barrons","summary":"Canopy Growth was downgraded at BofA Securities with the analysts noting “execution challenges and a","content":"<p>Canopy Growth&nbsp;was downgraded at BofA Securities with the analysts noting “execution challenges and a tough Canadian&nbsp;operating environment.”</p>\n<p>Analyst Lisa Lewandowski wrote in a note Wednesday that she sees “long-term potential for the legal cannabis industry driven by U.S. federal legalization and changing attitudes toward cannabis consumption,” but was downgrading the stock of Canopy Growth (ticker: CGC) to Underperform from Neutral.</p>\n<p>U.S.-listed shares of the Canadian cannabis company fell 3% to $9.37. The stock has declined 62% in 2021.</p>\n<p>Lewandowski said Canopy Growth’s relationship with&nbsp;Constellation Brands&nbsp;(STZ) was a plus, but the company “has shown&nbsp;mixed progress on key performance metrics, is&nbsp;confronted&nbsp;with&nbsp;a rapidly&nbsp;evolving&nbsp;Canadian market with new entrants taking&nbsp;market&nbsp;share&nbsp;and changing consumer tastes,&nbsp;lackluster industry growth&nbsp;even with&nbsp;new stores&nbsp;opening and&nbsp;limited visibility for&nbsp;profitability.”</p>\n<p>Constellation Brands owns a 36% stake in Canopy Growth, according to FactSet.</p>\n<p>Recent management changes at the company and the planned sale of C3, a German pharmaceutical company, were efforts at Canopy Growth that “will take time to show results,” the analyst said.</p>\n<p>BofA reduced its price target on U.S. shares to $7.94&nbsp;from&nbsp;$15.15.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canopy Growth Stock Is Downgraded Again, This Time on ‘Execution Challenges’</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanopy Growth Stock Is Downgraded Again, This Time on ‘Execution Challenges’\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 13:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/canopy-growth-cgc-stock-downgrade-cannabis-51640192812?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth was downgraded at BofA Securities with the analysts noting “execution challenges and a tough Canadian operating environment.”\nAnalyst Lisa Lewandowski wrote in a note Wednesday that she ...</p>\n\n<a href=\"https://www.barrons.com/articles/canopy-growth-cgc-stock-downgrade-cannabis-51640192812?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CGC":"Canopy Growth Corporation"},"source_url":"https://www.barrons.com/articles/canopy-growth-cgc-stock-downgrade-cannabis-51640192812?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1103220602","content_text":"Canopy Growth was downgraded at BofA Securities with the analysts noting “execution challenges and a tough Canadian operating environment.”\nAnalyst Lisa Lewandowski wrote in a note Wednesday that she sees “long-term potential for the legal cannabis industry driven by U.S. federal legalization and changing attitudes toward cannabis consumption,” but was downgrading the stock of Canopy Growth (ticker: CGC) to Underperform from Neutral.\nU.S.-listed shares of the Canadian cannabis company fell 3% to $9.37. The stock has declined 62% in 2021.\nLewandowski said Canopy Growth’s relationship with Constellation Brands (STZ) was a plus, but the company “has shown mixed progress on key performance metrics, is confronted with a rapidly evolving Canadian market with new entrants taking market share and changing consumer tastes, lackluster industry growth even with new stores opening and limited visibility for profitability.”\nConstellation Brands owns a 36% stake in Canopy Growth, according to FactSet.\nRecent management changes at the company and the planned sale of C3, a German pharmaceutical company, were efforts at Canopy Growth that “will take time to show results,” the analyst said.\nBofA reduced its price target on U.S. shares to $7.94 from $15.15.","news_type":1},"isVote":1,"tweetType":1,"viewCount":342,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856605792,"gmtCreate":1635171634857,"gmtModify":1635171635042,"author":{"id":"3577068348393147","authorId":"3577068348393147","name":"GerardBungee","avatar":"https://static.tigerbbs.com/ed18bbfb3b78ae0c31b89056409c9938","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RIOT\">$Riot Blockchain, Inc.(RIOT)$</a>long term potential?","listText":"<a href=\"https://laohu8.com/S/RIOT\">$Riot Blockchain, Inc.(RIOT)$</a>long term potential?","text":"$Riot Blockchain, Inc.(RIOT)$long term potential?","images":[{"img":"https://static.tigerbbs.com/0df16469a1cce9c32ef8adb73777328b","width":"1080","height":"2429"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/856605792","isVote":1,"tweetType":1,"viewCount":349,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":691707041,"gmtCreate":1640237607418,"gmtModify":1640237607478,"author":{"id":"3577068348393147","authorId":"3577068348393147","name":"GerardBungee","avatar":"https://static.tigerbbs.com/ed18bbfb3b78ae0c31b89056409c9938","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Ttm","listText":"Ttm","text":"Ttm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691707041","repostId":"1132132037","repostType":4,"repost":{"id":"1132132037","pubTimestamp":1640236963,"share":"https://www.laohu8.com/m/news/1132132037?lang=&edition=full","pubTime":"2021-12-23 13:22","market":"us","language":"en","title":"Netflix Stock: Why It Might Outperform Rivals in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1132132037","media":"TheStreet","summary":"Could 2022 be a great year for Netflix stock? Here's why shares of the streaming platform may outper","content":"<p>Could 2022 be a great year for Netflix stock? Here's why shares of the streaming platform may outperform its competitors again next year.</p>\n<p>After Netflix's&nbsp;great stock performance in 2021, fans of the streaming service are wondering what's in store for the company and its shares in 2022.</p>\n<p>Let's sum up what happened to NFLX shares this year and whether they still present a good opportunity for investors.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a2b3cf4fdc5d06fd34521575cb3c69b3\" tg-width=\"1240\" tg-height=\"812\" width=\"100%\" height=\"auto\"><span>Figure 1: Netflix's office.</span></p>\n<p><b>Netflix's 2021 Revenue Results</b></p>\n<p>Looking at company revenue, Netflix continued to grow during 2021 but experienced a slowdown compared to 2020. This was likely due to the subscription boom the company experienced during 2020 thanks to COVID lockdowns.</p>\n<p>Even so, during the last three quarters, Netflix's revenue showed year-over-year average revenue growth of 20%. In addition, its operating margins rose from 20.4% in the third quarter of 2020 to 23.5% in the third quarter of 2021.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2f704b36024b940ec42ace68116770a9\" tg-width=\"949\" tg-height=\"438\" width=\"100%\" height=\"auto\"><span>Figure 2: Netflix's financial statements.</span></p>\n<p>Subscriber growth is another key metric for investors. Unfortunately, results here were disappointing in 2021.</p>\n<p>In 2020, Netflix's subscriber growth was more than 20% per quarter. This dropped to 10% in 2021.</p>\n<p>However, investors should take it into account that, during the early months of the pandemic, the company experienced record-breaking growth. The decrease we've seen this year may just be the result of subscriber growth returning to normal levels.</p>\n<p><b>How Did NFLX Perform Against Other Streaming Services?</b></p>\n<p>Compared to its competitors, NFLX did very well in 2021 with cumulative growth of 16%. Other stocks that compete in the video streaming segment saw worse returns. For example, Amazon&nbsp;shares appreciated only 5%, while Disney&nbsp;suffered a drop of nearly 20%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bd970e1a30a0271380825554f364907d\" tg-width=\"811\" tg-height=\"428\" width=\"100%\" height=\"auto\"><span>Figure 3: AMZN, DIS, NFLX and SPY performance in 2021.</span></p>\n<p>However, NFLX's performance looks less stellar when compared to companies outside the streaming segment. In fact, the stock underperformed the S&amp;P 500 in 2021.</p>\n<p>As Netflix stock moves away from its peak in November, there may still be room for the company to grow.</p>\n<p><b>What's Next?: Our Take on NFLX for 2022</b></p>\n<p>Netflix was a pioneer in the video streaming segment. And despite fierce competition from giants like Disney and Amazon, it still has the largest market share in the industry.</p>\n<p>In addition, Netflix is constantly betting on new segments for revenue growth. For example, it recently pushed beyond films by launching an interactive games division. Moves like this expose Netflix to new subscribers and boost its bottom line.</p>\n<p>We believe that the recent fall in NFLX’s stock price translates to a buying opportunity for long-term investors who agree there’s still plenty of growth to come.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Netflix Stock: Why It Might Outperform Rivals in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNetflix Stock: Why It Might Outperform Rivals in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 13:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/streaming/nflx/netflix-stock-should-you-buy-nflx-shares-in-2022><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Could 2022 be a great year for Netflix stock? Here's why shares of the streaming platform may outperform its competitors again next year.\nAfter Netflix's great stock performance in 2021, fans of the ...</p>\n\n<a href=\"https://www.thestreet.com/streaming/nflx/netflix-stock-should-you-buy-nflx-shares-in-2022\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NFLX":"奈飞"},"source_url":"https://www.thestreet.com/streaming/nflx/netflix-stock-should-you-buy-nflx-shares-in-2022","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1132132037","content_text":"Could 2022 be a great year for Netflix stock? Here's why shares of the streaming platform may outperform its competitors again next year.\nAfter Netflix's great stock performance in 2021, fans of the streaming service are wondering what's in store for the company and its shares in 2022.\nLet's sum up what happened to NFLX shares this year and whether they still present a good opportunity for investors.\nFigure 1: Netflix's office.\nNetflix's 2021 Revenue Results\nLooking at company revenue, Netflix continued to grow during 2021 but experienced a slowdown compared to 2020. This was likely due to the subscription boom the company experienced during 2020 thanks to COVID lockdowns.\nEven so, during the last three quarters, Netflix's revenue showed year-over-year average revenue growth of 20%. In addition, its operating margins rose from 20.4% in the third quarter of 2020 to 23.5% in the third quarter of 2021.\nFigure 2: Netflix's financial statements.\nSubscriber growth is another key metric for investors. Unfortunately, results here were disappointing in 2021.\nIn 2020, Netflix's subscriber growth was more than 20% per quarter. This dropped to 10% in 2021.\nHowever, investors should take it into account that, during the early months of the pandemic, the company experienced record-breaking growth. The decrease we've seen this year may just be the result of subscriber growth returning to normal levels.\nHow Did NFLX Perform Against Other Streaming Services?\nCompared to its competitors, NFLX did very well in 2021 with cumulative growth of 16%. Other stocks that compete in the video streaming segment saw worse returns. For example, Amazon shares appreciated only 5%, while Disney suffered a drop of nearly 20%.\nFigure 3: AMZN, DIS, NFLX and SPY performance in 2021.\nHowever, NFLX's performance looks less stellar when compared to companies outside the streaming segment. In fact, the stock underperformed the S&P 500 in 2021.\nAs Netflix stock moves away from its peak in November, there may still be room for the company to grow.\nWhat's Next?: Our Take on NFLX for 2022\nNetflix was a pioneer in the video streaming segment. And despite fierce competition from giants like Disney and Amazon, it still has the largest market share in the industry.\nIn addition, Netflix is constantly betting on new segments for revenue growth. For example, it recently pushed beyond films by launching an interactive games division. Moves like this expose Netflix to new subscribers and boost its bottom line.\nWe believe that the recent fall in NFLX’s stock price translates to a buying opportunity for long-term investors who agree there’s still plenty of growth to come.","news_type":1},"isVote":1,"tweetType":1,"viewCount":678,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":845132423,"gmtCreate":1636299004466,"gmtModify":1636299004587,"author":{"id":"3577068348393147","authorId":"3577068348393147","name":"GerardBungee","avatar":"https://static.tigerbbs.com/ed18bbfb3b78ae0c31b89056409c9938","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/845132423","repostId":"843244545","repostType":1,"repost":{"id":843244545,"gmtCreate":1635836949483,"gmtModify":1636092763588,"author":{"id":"3579612413176972","authorId":"3579612413176972","name":"Yonny","avatar":"https://static.tigerbbs.com/231a2860cddd1bf2ffc3c16938f4673d","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"title":"Rivian is a better buy than Lucid, IMO","htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/RIVN\">$Rivian Automotive, Inc.(RIVN)$</a>,the&nbsp;EV&nbsp;automaker and automotive technology company&nbsp;is&nbsp;going&nbsp;to go public as soon as next week,&nbsp;and&nbsp;retail traders can&nbsp;get into&nbsp;the IPO&nbsp;on&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>.&nbsp; Rivian&nbsp;said&nbsp;it is offering 135 million shares priced between $57 and $62,&nbsp;putting valuation up&nbsp;to&nbsp;near $55 billion.&nbsp;And&nbsp;the&nbsp;company&nbsp;is&nbsp;backed by&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/AMZN\">$Amazon.com(AMZN)$</a> and&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/F\">$Ford(F)$</a> So&nbsp;compared&nbsp;to&nbsp;","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/RIVN\">$Rivian Automotive, Inc.(RIVN)$</a>,the&nbsp;EV&nbsp;automaker and automotive technology company&nbsp;is&nbsp;going&nbsp;to go public as soon as next week,&nbsp;and&nbsp;retail traders can&nbsp;get into&nbsp;the IPO&nbsp;on&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>.&nbsp; Rivian&nbsp;said&nbsp;it is offering 135 million shares priced between $57 and $62,&nbsp;putting valuation up&nbsp;to&nbsp;near $55 billion.&nbsp;And&nbsp;the&nbsp;company&nbsp;is&nbsp;backed by&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/AMZN\">$Amazon.com(AMZN)$</a> and&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/F\">$Ford(F)$</a> So&nbsp;compared&nbsp;to&nbsp;","text":"$Rivian Automotive, Inc.(RIVN)$,the EV automaker and automotive technology company is going to go public as soon as next week, and retail traders can get into the IPO on $SoFi Technologies Inc.(SOFI)$. Rivian said it is offering 135 million shares priced between $57 and $62, putting valuation up to near $55 billion. And the company is backed by $Amazon.com(AMZN)$ and $Ford(F)$ So compared to","images":[{"img":"https://static.tigerbbs.com/2547c8ce512a5377c138129416f63e64","width":"1780","height":"680"}],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843244545","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":519,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846880415,"gmtCreate":1636072707706,"gmtModify":1636072707778,"author":{"id":"3577068348393147","authorId":"3577068348393147","name":"GerardBungee","avatar":"https://static.tigerbbs.com/ed18bbfb3b78ae0c31b89056409c9938","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PATH\">$UiPath(PATH)$</a>great potential !","listText":"<a href=\"https://laohu8.com/S/PATH\">$UiPath(PATH)$</a>great potential !","text":"$UiPath(PATH)$great potential !","images":[{"img":"https://static.tigerbbs.com/6b2be22fd819b32b2426fddd05133612","width":"1080","height":"2528"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846880415","isVote":1,"tweetType":1,"viewCount":622,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":849477604,"gmtCreate":1635775742226,"gmtModify":1635775742291,"author":{"id":"3577068348393147","authorId":"3577068348393147","name":"GerardBungee","avatar":"https://static.tigerbbs.com/ed18bbfb3b78ae0c31b89056409c9938","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PSFE\">$Paysafe Ltd(PSFE)$</a>yay or nay?","listText":"<a href=\"https://laohu8.com/S/PSFE\">$Paysafe Ltd(PSFE)$</a>yay or nay?","text":"$Paysafe Ltd(PSFE)$yay or nay?","images":[{"img":"https://static.tigerbbs.com/8a848c0d4f7c259222fcb06e09bed5dc","width":"1080","height":"2429"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849477604","isVote":1,"tweetType":1,"viewCount":460,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"lives":[]}